Medtech M&A: Build to Be Bought
How to build, position, and operate your medtech company to attract premium acquirers — on your terms.
What is this course about?
Most medtech companies don’t IPO — they exit through acquisition. But the best exits don’t happen by chance. They’re the result of years of preparation, smart execution, and the right relationships. This 8-week course delivers 16 actionable lessons straight to your inbox. You’ll learn how to adopt the right mindset, build operational excellence, and create a continuous value engine that positions your company for maximum leverage when it matters most.
Week 1: Build to Be Bought
Learn why chasing an exit rarely works, and why acquirers gravitate toward companies built for long-term impact. This week explores how to create sustainable growth, cultivate relationships with strategics years in advance, and set the stage for being bought, not sold.
Week 2: Operational Readiness & Due Diligence
Strong clinical results aren’t enough. Acquirers dig deep into your quality systems, audits, financials, and HR. You’ll see how operational excellence and audit-ready discipline can make or break a valuation — and why due diligence is the true test of your company’s credibility.
Week 3: Milestones & Timing
Certain inflection points — regulatory approvals, pivotal data, commercial traction — can systematically de-risk your business and increase negotiating power. You’ll also learn how to align your progress with a strategic’s priorities to engage them at a moment of maximum leverage.
Week 4: Decoding Acquirers & Finding Champions
Acquirers always assess the same core criteria: market size, risk profile, traction, and competitive edge. This week explores how to anticipate these discussions and position your technology as a strategic fit. You’ll also learn how to identify and empower internal champions who will advocate for your deal from the inside.
Week 5: Trust & Multi-Bidder Leverage
This week explores how transparency during due diligence builds trust — and how trust reduces perceived risk. You’ll also see how involving multiple bidders creates healthy competition that increases value, shortens timelines, and gives you more control over deal terms.
Week 6: Protecting & Positioning
Due diligence can drain resources and stall momentum. This week, you’ll learn how to safeguard your company with breakup clauses, set realistic timelines, and shield your team from unnecessary distraction. You’ll also learn how to assess whether you’re a “tuck-in” acquisition or a true category creator, and why that distinction shapes valuation.
Week 7: Partnerships & Alliances
The path to acquisition doesn’t always start with capital raises. You’ll learn how strategic partnerships and co-opetition can validate your technology, reduce costs, and accelerate market entry. Done right, these alliances de-risk your business and signal value to both investors and acquirers.
Week 8: Premium Valuation & Wrap-Up
Premium exits are engineered, not left to chance. This week, you’ll learn how to expand into adjacent markets, align with market trends, and design offerings that unlock new growth paths — all levers that drive premium valuations. The course concludes with three core principles that tie everything together, emphasizing the value creation engine as the foundation for long-term success.
Unlock the Full Course
